Novo Nordisk 29. Apr. 2026 Canada Approves Dr. Reddy’s Generic Version of Novo Nordisk’s Ozempic - WSJ
Novo Nordisk 29. Apr. 2026 Novo Nordisk faces competition from Canadian generic version of Ozempic - medwatch.com
Novo Nordisk 28. Apr. 2026 Novo Holdings makes 1st commitment to Korean PEF as global pharma capital targets K-bio - KED Global
Novo Nordisk 27. Apr. 2026 The 10 Most Influential Health and Life Science Companies of 2026 - Time Magazine
Novo Nordisk 23. Apr. 2026 With trial win, Novo Nordisk eyes adolescent diabetes approval for oral semaglutide - Fierce Pharma
Novo Nordisk 20. Apr. 2026 Novo Nordisk to seek oral sickle cell therapy approval after Phase III victory - Clinical Trials Arena
FierceBiotech 8. Apr. 2026 With $2B Novo deal in the books, Vivtex isn't 'limited to being just a drug delivery company': CEO
Endpoints News 7. Apr. 2026 Novo launches high-dose Wegovy in the US; Evotec pressured to list its US unit
Endpoints News 1. Apr. 2026 Novo cuts 400 jobs in Indiana as Scholar Rock refiles drug linked to the factory
FierceBiotech 1. Apr. 2026 KBP hopes to revive troubled heart drug at center of deal fraud dispute with Novo Nordisk
Endpoints News 25. März 2026 Novo reports more triple-G data from China; Grifols plots IPO for biopharma unit
FierceBiotech 25. März 2026 Novo Nordisk prepares to go global as triple-G prospect passes midphase diabetes test in China
Endpoints News 19. März 2026 Novo wins FDA approval for high-dose Wegovy under commissioner's voucher